See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Atripla
Generic Name: Efavirenz-Emtricitabine-Tenofovir
What is Efavirenz-Emtricitabine-Tenofovir? The combination of efavirenz, emtricitabine, and tenofovir, three widely used antiretroviral drugs, is designed to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.
See more information, including instructions, precautions, side effects, and interactions.
389 patients in the community are taking or have taken Efavirenz-Emtricitabine-Tenofovir.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat my HIV | 304 | 78% |
| Other | 9 | 2% |
| Improve immune function | 7 | 1% |
| General health | 3 | <1% |
| Don't know | 2 | <1% |
| none | 2 | <1% |
| Muscle fatigue, dry mouth. | 1 | <1% |
| Anxiety | 1 | <1% |
| Depression | 1 | <1% |
Other treatments patients are taking for Treat my HIV include Emtricitabine-Tenofovir, Ritonavir, and Atazanavir.
Based on the patients currently taking Efavirenz-Emtricitabine-Tenofovir.
Top 10 (Show all)
All (Show top 10)
| daily | 1 daily | 1 mg daily | 1 tbs. daily | 2 tbs. daily | 10 g daily | 200 mg daily | 250 mg daily | 300 mg daily | 500 mg daily | 600 daily | 600 mg-200 mg-300 mg daily | 600 mg daily | 800 mg daily | 1100 mg daily | 1200 mg daily | 2 x 600 mg-200 mg-300 mg daily | 3 x 600 mg-200 mg-300 mg daily | 30 x 600 mg-200 mg-300 mg daily | 100 x 600 mg-200 mg-300 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
32
|
14
|
2
|
5
|
1
|
1
|
5
|
1
|
2
|
2
|
1
|
243
|
27
|
1
|
5
|
1
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Efavirenz-Emtricitabine-Tenofovir or how long patients were taking Efavirenz-Emtricitabine-Tenofovir before stopping.
Results from 86 patient evaluations. See the overall results and all individual evaluations.
| Major | 73% | 60 |
|---|---|---|
| Moderate | 9% | 7 |
| Slight | 5% | 4 |
| Can't tell | 13% | 11 |
Treat my HIV
| Severe | 12% | 10 |
|---|---|---|
| Moderate | 20% | 17 |
| Mild | 45% | 39 |
| None | 23% | 20 |
Top reported side-effects include: Vivid dreams, tiredness, Dizziness
Summary results are based on 86 individual responses. For more information, see overall results for Adherence, Burden and Cost.
See all evaluation results for Efavirenz-Emtricitabine-Tenofovir
Report created on November 08, 2009.